GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

TFBS Bioscience 6939.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

18.20

+0.28%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 193.1m

FY2020FY2025

Net income

−TWD 74.5m

FY2020FY2025

Free cash flow

−TWD 235.2m

FY2020FY2025

Shareholders' equity

TWD 1.16bn

FY2020FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
RevenueTWD 193.1mTWD 180.6mTWD 231.9mTWD 252.7mTWD 160.9mTWD 118.6m
Gross profitTWD 36.8mTWD 37.5mTWD 63.3mTWD 104.0mTWD 54.0mTWD 34.6m
Research and developmentTWD 64.8mTWD 45.7mTWD 36.2mTWD 33.7mTWD 26.0mTWD 21.0m
Operating income−TWD 78.0m−TWD 61.2m−TWD 5.5mTWD 33.8mTWD 6.0mTWD 311,000
Net income−TWD 74.5m−TWD 38.7mTWD 4.9mTWD 27.7mTWD 6.1mTWD 296,000
Diluted earnings per share-2.13-1.110.140.790.180.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Total assetsTWD 1.46bnTWD 1.50bnTWD 1.45bnTWD 1.36bnTWD 491.3mTWD 288.4m
Cash and short-term investments—TWD 693.9mTWD 979.3mTWD 1.03bnTWD 240.9mTWD 76.1m
Total liabilitiesTWD 294.7mTWD 265.1mTWD 187.4mTWD 126.2mTWD 66.4mTWD 40.4m
Debt—TWD 196.2mTWD 131.8mTWD 52.2mTWD 21.4mTWD 19.7m
Shareholders' equityTWD 1.16bnTWD 1.23bnTWD 1.26bnTWD 1.24bnTWD 424.9mTWD 247.9m
Shares outstanding35m35m35m35m35m35m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations−TWD 9.7mTWD 28.8mTWD 36.5mTWD 78.7mTWD 21.0mTWD 29.4m
Capital spending−TWD 225.4m−TWD 372.8m−TWD 55.9m−TWD 49.8m−TWD 19.0m−TWD 13.3m
Free cash flow−TWD 235.2m−TWD 344.0m−TWD 19.4mTWD 28.9mTWD 2.0mTWD 16.1m
Dividends paid—−TWD 1.7m−TWD 3.3m———

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023
RevenueTWD 87.0mTWD 89.0mTWD 91.6mTWD 116.8mTWD 115.1m
Gross profitTWD 9.9mTWD 9.0mTWD 12.6mTWD 31.9mTWD 31.4m
Operating income−TWD 41.9m−TWD 35.4m−TWD 23.2m−TWD 12.6mTWD 7.2m
Net income−TWD 39.9m−TWD 19.6m−TWD 19.1m−TWD 3.1mTWD 8.1m
Diluted earnings per share-1.14-0.56-0.55-0.090.23
Cash from operations−TWD 14.0mTWD 8.0mTWD 20.0mTWD 7.0mTWD 28.0m
Capital spending−TWD 126.0m−TWD 175.0m−TWD 196.0m−TWD 30.0m−TWD 24.0m
Free cash flow−TWD 140.0m−TWD 167.0m−TWD 176.0m−TWD 23.0mTWD 4.0m
Total assetsTWD 1.52bnTWD 1.50bnTWD 1.42bnTWD 1.45bnTWD 1.35bn
Cash and short-term investmentsTWD 546.9mTWD 693.9mTWD 784.1mTWD 979.3mTWD 1.02bn
DebtTWD 129.3mTWD 119.8mTWD 60.7mTWD 59.9mTWD 20.1m
Shareholders' equityTWD 1.19bnTWD 1.23bnTWD 1.25bnTWD 1.26bnTWD 1.26bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-8.6%10.2%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin19.9%28.2%29.0%—
Operating margin-37.3%-12.9%-9.2%—
Net margin-30.3%-9.4%-6.5%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023
Price to earnings-9.8-25.6323.2
Price to sales3.85.56.8

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 9 Aug 2024.

FY2024FY2023
Paid in the year0.050.10
  • 1040-for-1000 split · 27 Sept 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.